SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-287501
Filing Date
2023-12-01
Accepted
2023-12-01 16:35:34
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d936158ds3.htm S-3 419245
2 EX-1.2 d936158dex12.htm EX-1.2 180400
3 EX-4.3 d936158dex43.htm EX-4.3 264398
4 EX-5.1 d936158dex51.htm EX-5.1 28754
5 EX-5.2 d936158dex52.htm EX-5.2 11780
6 EX-23.1 d936158dex231.htm EX-23.1 1581
7 EX-FILING FEES d936158dexfilingfees.htm EX-FILING FEES 45974
8 GRAPHIC g936158g01a03.jpg GRAPHIC 70077
9 GRAPHIC g936158g01a56.jpg GRAPHIC 85498
10 GRAPHIC g936158sp3.jpg GRAPHIC 2155
  Complete submission text file 0001193125-23-287501.txt   1170789
Mailing Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 617-207-8979
Acrivon Therapeutics, Inc. (Filer) CIK: 0001781174 (see all company filings)

IRS No.: 825125532 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275854 | Film No.: 231460058
SIC: 2834 Pharmaceutical Preparations